Ledger.Open graph →
SEC Form D · filed May 4, 2020

Taysha Gene Therapies, Inc

Offering
$30.0M
Sold
$18.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DALLAS, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Sean A. Nolan · Dallas, TXDirectorPaul B. Manning · Dallas, TXDirectorElizabeth Zuchelkowski · Detroit, MIDirectorSteve A. Cobb · Carmel, INDirectorR.A. Session Ii · Dallas, TXExec · DirectorLaura Witt · PARK CITY, UTDirectorTodd Forrest · PARK CITY, UTDirectorR.A. Session Ii · Dallas, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗